share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Adial Pharmaceuticals | 4:持股變動聲明
美股SEC公告 ·  03/27 18:25

Moomoo AI 已提取核心訊息

In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
在最近於2024年3月25日進行的一筆交易中,與艾迪爾製藥(ADIL.US)相關的羅伯遜·吉利蘭參與了一次股市事件。有關交易性質的具體細節,例如交易的股票數量、交易價格和由此產生的股權,沒有披露。關注Adial Pharmicals的投資者可能會對這一事件感興趣,因爲內幕交易可以爲公司的財務狀況和未來前景提供見解。
在最近於2024年3月25日進行的一筆交易中,與艾迪爾製藥(ADIL.US)相關的羅伯遜·吉利蘭參與了一次股市事件。有關交易性質的具體細節,例如交易的股票數量、交易價格和由此產生的股權,沒有披露。關注Adial Pharmicals的投資者可能會對這一事件感興趣,因爲內幕交易可以爲公司的財務狀況和未來前景提供見解。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息